Diuretics revisited - Again

Journal of Clinical Hypertension

Volumn 3, Issue 3, 2001, Pages 136-138

  Moser, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; ISRADIPINE; LIPID; NIFEDIPINE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADULT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; DRUG TOLERABILITY; EDITORIAL; GLUCOSE METABOLISM; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOKALEMIA; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE;

EID: 0034956489     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2001.00468.x     Document Type: Editorial

References (35)

1. Why are physicians not prescribing diuretics more frequently in the management of hypertension?
2. Lipid abnormalities and diuretics
3. Cardiotoxicity and diuretics: Much speculation-little substance
4. Current hypertension management: Separating fact from fiction
5. Suppositions and speculations-their possible effects on treatment decisions in the management of hypertension
6. The effect of antihypertensive drugs on serum lipids and lipoproteins, I: Diuretics
7. New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension
8. Alternatives to traditional antihypertension therapy
9. Serum lipoprotein during antihypertensive therapy with beta blockers and diuretics: A controlled long-term comparative trial
10. Hypertension and sudden death: Disparate effects of calcium entry blockers and diuretic therapy on cardiac dysrhythmias
11. Trends in pharmacologic management of hypertension in the United States
12. Clinical trials and their effect on medical therapy: The Multiple Risk Factor Intervention Trial
13. Who really determines your patients' prescriptions?
14. Implications of the systolic hypertension in the elderly program
15. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38
16. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-1 study
17. The treatment of hypertension in diabetic patients
18. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus
19. Diuretic-induced ventricular ectopic activity
20. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension
21. Diuretic therapy and risk of cardiac arrest
22. Treatment of Mild Hypertension Study (TOHMS). Final results
23. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
24. Antihypertensive drug therapy and regression of left ventricular hypertrophy: A review with a focus on diuretics
25. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in the hypertension treatment trials
26. Advantage of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
27. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease
28. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
29. Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness
30. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
31. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo; results of a Department of Veterans Affairs Cooperative Study
32. Antihypertensive drug therapies and the risk of ischemic stroke
33. Relationship of quality of life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study